Pseudo-Chediak-Higashi inclusions in a case of acute lymphoblastic leukemia
Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology
Post-liver transplant myeloid maturation arrest
A case of primary plasma cell leukemia exhibiting hemophagocytic plasma cells relapsed with multiple cutaneous plasmacytoma
Blood Res 2018; 53(2): 95~181
How much progress has Blood Research made since the change of the journal title in 2013
Sun Huh, M.D.
Blood Res 2018; 53(2): 95-100 PDF PubMed Central
Images of Hematology
The ubiquitous parasite: leishmaniasis in an elderly man
Mili Jain, Ashutosh Kumar, Shailendra Prasad Verma et al.
Blood Res 2018; 53(2): 101 PDF PubMed Central
Megakaryoblasts in a newborn with Down syndrome
Sabrina Buoro, Michela Seghezzi, Gianmaria Borleri et al.
Blood Res 2018; 53(2): 102 PDF PubMed Central
Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation
Tanmoy Mandal, Anuj Verma, Vikas Talreja et al.
Blood Res 2018; 53(2): 103 PDF PubMed Central
Del(5q) myelodysplastic syndrome combined with pure red cell aplasia
Joowon Park
Blood Res 2018; 53(2): 104 PDF PubMed Central
Original Articles
Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
Ja Min Byun, Jayoun Lee, Sang-Jin Shin et al.
Blood Res 2018; 53(2): 105-109 PDF PubMed Central
Clinical characteristics and treatment courses for cytomegalovirus-associated thrombocytopenia in immunocompetent children after neonatal period
Min Ji Jin, Yunkyum Kim, Eun Mi Choi et al.
Blood Res 2018; 53(2): 110-116 PDF PubMed Central
Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
Naohiro Sekiguchi, Airi Hamano, Tomoko Kitagawa et al.
Blood Res 2018; 53(2): 117-122 PDF PubMed Central
Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
Sung-Eun Lee, Young-Woo Jeon, Jae-Ho Yoon et al.
Blood Res 2018; 53(2): 123-129 PDF PubMed Central Supplementary File
Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia
Yee Yee Yap, Jameela Sathar, Kian Boon Law et al.
Blood Res 2018; 53(2): 130-137 PDF PubMed Central
Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis
Nadia El-Menshawy, Sherin M. Abd-Aziz, Enas M Elkhamisy et al.
Blood Res 2018; 53(2): 138-144 PDF PubMed Central
Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin
Bo-Kyoung Park, Hyo-Sup Kim, Seongkoo Kim et al.
Blood Res 2018; 53(2): 145-151 PDF PubMed Central
Original Articles
The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)
Željka Tkalčić Švabek, Marina Josipović, Ivana Horvat et al.
Blood Res 2018; 53(2): 152-159 PDF PubMed Central
Letters to the Editor
Synchronous hairy cell leukemia and chronic lymphocytic leukemia: a case report with a brief review of literature
Pulkit Rastogi, Preethi Jeyaraman, Man Updesh Sachdeva et al.
Blood Res 2018; 53(2): 160-163 PDF PubMed Central
The first concurrent diagnosis of acute symptomatic Babesiosis and chronic myeloid leukemia in a healthy young adult
Yan Xie, Valeria Visconte, Lei Duan et al.
Blood Res 2018; 53(2): 163-166 PDF PubMed Central
Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center
Aishwarya Ravindran, Ronald S. Go, Kaaren K. Reichard et al.
Blood Res 2018; 53(2): 166-167 PDF PubMed Central
Microangiopathic hemolytic anemia as initial presentation of recurrent colon cancer
Joowon Park
Blood Res 2018; 53(2): 167-169 PDF PubMed Central
Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As2O3) and all-trans retinoic acid (ATRA)
Preetesh Jain, Sergej Konoplev, Ohad Benjamini et al.
Blood Res 2018; 53(2): 169-172 PDF PubMed Central
Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
Simon Kavanagh, Vera Bril, and Jeffrey H Lipton
Blood Res 2018; 53(2): 172-174 PDF PubMed Central
Primary CNS lymphoma: latest updates and a 10-year monocenter experience
Emanuele Cencini, Alberto Fabbri, Luana Schiattone et al.
Blood Res 2018; 53(2): 174-177 PDF PubMed Central
Acetate moderately attenuates the generation of neutrophil extracellular traps
Ayako Ohbuchi, Mari Kono, Mariko Takenokuchi et al.
Blood Res 2018; 53(2): 177-180 PDF PubMed Central
Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia
Sweta Rajpal, Ram V. Nampoothiri, Sreejesh Sreedharanunni et al.
Blood Res 2018; 53(2): 180-181 PDF PubMed Central
Blood Res 2018; 53(2): 182 PDF PubMed Central

Current Issue

25 June 2018 Volume 53.
Number 2 pp. 95~181
Today : 33  /
Total : 103,076